Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0476089 (endometrial cancer)
 11,379 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

This article, prepared by the medical consultant to the International Planned Parenthood Federation, reviews recent evidence regarding oral contraceptives (OCs) and cancers of the reproductive organs. Several case-control and prospective studies not only have shown that OCs do not increase the risk of cancer of the endometrium or ovary, but also that OC use exerts a protective effect against the development of these cancers. The current evidence suggests that there is no overall increase in the risk of breast cancer among OC users, but the possibility that particular groups of women (i.e., those with a history of benign breast disease or a family history of breast cancer, those who used OCs before their 1st full-term pregnancy, and women who used OCs before the age of 25 years) may be at higher risk cannot be excluded. There have been reports that breast cancer tumors have more favorable outcomes in OC users than in nonusers. Finally, the evidence that the risk of cervical cancer may be slightly increased by prolonged OC use is stronger, but not yet definitely confirmed. Most of the studies that have found an increased risk of cervical dysplasia or carcinoma of the cervix among OC users have not controlled properly for selection, diagnostic, or confounding bias. It is noted that many of the OC users included in epidemiologic studies were taking OCs marketed in the early 1960s that contained higher doses of estrogen and progestagen than preparations on the market today. Given the lack of conclusive evidence regarding the risk of cervical dysplasia and malignancy in OC users, cervical smears should be obtained on a regular basis. Despite these cautionary measures, it is concluded that OCs remain one of the most reliable methods of contraception available.
 ...
PMID:Oral contraceptives and cancer of the reproductive organs. 1226 11

We express the mass screening data of uterine cervical cancer, endometrial cancer, and ovarian cancer in Japan. The increase in cervical cancer mass screening rate, correlate well with decreasing mortality for uterine cancer, but mortality is re-increasing now. It is concern to increase of uterine cervical dysplasia and cervical cancer of young women. Then, we need to start the screening for more young women. The detect ratio of uterine corpus cancer is increasing now. Then, we need to change the object, and introduce new screening method for example, trans vaginal echogram. Ovarian cancer screening method is not establishment, but mortality rate in patients with ovarian cancer will be increase in future. Trans vaginal echogram is the better method for the screening. On the economical reason, we have a tendency the cancer screenings are neglected. It is important to watch the policy of health carefully.
 ...
PMID:[Problem of uterine and ovarian cancer mass screening]. 1246 89

Optical coherence tomography is one of the most important technological progress of the last ten years in the field of medical imaging. It is similar to ultrasound imaging except that it uses properties of light instead of ultrasound. Optical coherence tomography provides images of tissue structure, and at a cellular level, in situ, in real time, with much better spatial resolution than ultrasound and without removal of tissue (optical biopsy). Using optical coherence tomography in combination with catheters or endoscopes may enable the imaging of internal organs as the cervix, the uterine tissue and the ovary. The use of optical coherence tomography in the gynecological field is still experimental and is mainly about the in vitro and in vivo diagnosis of cervical dysplasia, cervical cancer, ovary cancer, endometrial cancer and endometriosis. We aim to present the principles of optical coherence tomography and to expose the main ways of research and the future and potential clinical applications of this technique in gynecology.
 ...
PMID:[The role and value of optical coherence tomography in gynecology]. 1782 59


<< Previous 1 2